Evidence map›Paper›PMID 41939251›Full record

ArticleHemaSphere2026

CD3xCD20 bispecific antibodies in transformed Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.

Morgane Brocard, Damien Roos-Weil, Lukshe Kanagaratnam, Thomas Hueso, Lucile Bussot, Benjamin Papoular, Cécile Tomowiak, Steeve Chevreux, Gilles Crochet, Tristan Vaugeois and 6 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Morgane BrocardDepartment of Hematology CHU de Reims Reims France.
Damien Roos-WeilSorbonne Université, Department of Hematology Hôpital Pitié Salpêtrière Paris France.
Lukshe KanagaratnamRecherche Clinique et Santé Publique, CHU de Reims, UFR 3797, Vieillissement, Fragilité (VieFra) Université de Reims Champagne-Ardenne Reims France.
Thomas HuesoDepartment of Hematology Institut Gustave Roussy Paris France.ORCID https://orcid.org/0000-0003-3354-332X
Lucile BussotDepartment of Hematology CHU de Grenoble Grenoble France.
Benjamin PapoularDepartment of Hematology CH d'Argenteuil Argenteuil France.
Cécile TomowiakHématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie CHU de Poitiers Poitiers France.
Steeve ChevreuxDepartment of Hematology CHU de Dijon Dijon France.
Gilles CrochetDepartment of Hematology CHU UCLouvain Namur Yvoir Belgium.
Tristan VaugeoisImmuno-Hematology, Hôpital Saint-Louis Paris France.
Elise ToussaintDepartment of Hematology Hôpitaux Universitaires de Strasbourg Strasbourg France.
Simone FerreroDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences University of Torino Torino Italy.
Charalampia KyriakouDepartment of Haematology University College London Hospitals, NHS Foundation Trust London United Kingdom.
Anne QuinquenelDepartment of Hematology CHU de Reims Reims France.
Prashant KapoorDivision of Hematology, Department of Internal Medicine Mayo Clinic Rochester Minnesota United States.
Eric DurotDepartment of Hematology CHU de Reims Reims France.ORCID https://orcid.org/0000-0003-3463-0089

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41939251
PMCPMC13045443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.